MYBL2 and melanoma: Kaplan–Meier analysis based on TCGA data revealed that high MYBL2 expression level was positively correlated with poorer progression-free survival of melanoma patients in the cohort of cutaneous melanoma (p = 0.0141, Figure 1E).